DuPont (DD)
NYSEMaterialsSpecialty ChemicalsSnapshot 2026-07-08
$136.97-1.89%
Close 2026-07-08 · 1-day change
Reading DD? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track DD free→NYSEMaterialsSpecialty ChemicalsSnapshot 2026-07-08
Reading DD? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track DD free→QuarterlyIQ Insights · DD
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 14 valuation methods, at three horizons. Current price $136.97. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $140 DD trades at 43× p/e — 1.9× the 23× p/e peer median, and above its own 18× history. The market is re-rating it beyond its own range; our $46 fair value is low-confidence here. Analysts target $53–$60. Note: our $46 fair value sits below the entire analyst range ($53–$60). The flat-multiple read looks rich, but earnings are inflecting up — trailing growth is accelerating and forward estimates confirm — so we've softened our read rather than brand an accelerating name expensive. Not investment advice.
$53.00 – $60.00 (median $57.50) · 4 analysts · as of 2026-06-15
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Only expensive valuation — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
At today's price the business can't be justified by any reasonable horizon of the forecast growth; the price already runs past what the model can underwrite. These describe the expectations embedded in the price, not a forecast of the move. Reverse-DCF base: $0.91/sh owner earnings.
Looks more expensive than peers.
Richer than its own typical valuation.
Trailing four: 2025-Q2, 2025-Q3, 2025-Q4, 2026-Q1
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $57.50 | — | — | Analyst | high |
| dcf fcfe | 12M | $69.04 | — | — | Analyst | high |
| dcf fcff | 12M | $65.99 | — | — | Analyst | high |
| ddm gordon | 12M | $20.60 | — | — | TTM | high |
| graham number | 12M | $49.99 | — | — | TTM | high |
| Mgmt guidance | 12M | $36.97 | 22.3 | 1.66 | Mgmt | high |
| Peer EV/EBITDA | 12M | $43.04 | 15.4 | 3.19 | TTM | high |
| Peer P/FCF | 12M | $42.20 | 21.6 | 1.95 | TTM | high |
| Peer P/E | 12M | $41.32 | 22.3 | 1.85 | TTM | high |
| Peer P/S | 12M | $22.92 | 1.4 | 16.76 | TTM | high |
| PEG | 12M | $36.02 | 19.4 | 1.85 | TTM | high |
| residual income | 12M | $34.13 | — | — | TTM | high |
| Own P/E history | 12M | $33.97 | 18.3 | 1.85 | TTM | high |
| triangulated | 12M | $76.26 | 22.3 | 3.42 | Triangulated | high |
| Mgmt guidance | 3Y | $226.28 | 22.3 | 10.16 | Mgmt(prov.) | medium |
| Peer P/E | 3Y | $40.39 | 22.3 | 1.81 | Analyst | medium |
| Peer P/S | 3Y | $24.25 | 1.4 | 17.73 | guidance | medium |
| PEG | 3Y | $35.21 | 19.4 | 1.81 | Analyst | medium |
| Own P/E history | 3Y | $33.21 | 18.3 | 1.81 | Analyst | medium |
| Mgmt guidance | 5Y | $757.11 | 22.3 | 33.99 | Mgmt(prov.) | medium |
| Peer P/E | 5Y | $39.48 | 22.3 | 1.77 | Analyst | medium |
| Peer P/S | 5Y | $23.71 | 1.4 | 17.33 | guidance | medium |
| PEG | 5Y | $34.42 | 19.4 | 1.77 | Analyst | medium |
| Own P/E history | 5Y | $32.46 | 18.3 | 1.77 | Analyst | medium |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.